国家中医药管理局召开2018年度中医药国际合作专项工作会议

2018-08-30 佚名 中国中医

国家中医药管理局国际合作司在京召开了2018年度中医药国际合作专项工作会议。国际合作司司长王笑频出席会议并作主旨讲话。

国家中医药管理局国际合作司在京召开了2018年度中医药国际合作专项工作会议。国际合作司司长王笑频出席会议并作主旨讲话。

会上,国际合作司就2015?2018年度中医药国际合作专项工作进展情况做了专题报告。会议听取了中国中医科学院、黑龙江中医药大学、云南中医药大学、山西中医药大学、广东省中医院、上海中医药大学等7家专项承担单位的经验分享,并听取了局规划财务司对中医药国际合作专项财政绩效考核要求的专题介绍。会议还围绕如何进一步执行好2018年度国际合作专项项目进行了讨论。

会议肯定了专项工作四年来取得的工作成效,共开展了49个海外中心和43个国内基地的创建工作,遍布全球五个大洲、35个国家,来自全国27个省市自治区的82家中医药机构和企业参与了专项建设工作,此外还制定了一批中医药国际标准,不少项目得到了国家领导人和外国元首的高度重视和评价。会议指出,中医药国际合作专项开展以来,在外交、商务、文化等领域上,体现出世界影响力,并在推动中医药海外立法、纳入当地医保、让中医进入主流医学等方面发挥了重要作用。

王笑频在讲话中指出,中医药国际合作专项工作尽管取得了可喜的阶段性成果,但也还面临着诸多困难和挑战,中医药“走出去”是一个长期、艰巨的任务,需要把专项工作纳入各省中医药工作和各单位发展全局中统筹谋划,对中医药“走出去”面临的形势进行全面分析,保证项目的可持续运营和长期发展,为项目搭建高效畅通的执行平台。同时要求各省级中医药管理部门积极督促专项项目承担单位做好2018年度中医药国际合作专项工作,严格按照项目实施期限,完成财政预算执行。

国家中医药管理局国际合作司及规划财务司负责同志、专项办公室负责人、各省级中医药管理部门负责人、2018年度项目承担单位负责人及相关人员共90余人出席会议。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2080579, encodeId=c94a20805e988, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Jan 17 00:51:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957536, encodeId=6f88195e5366f, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Oct 15 09:51:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771280, encodeId=25d41e7128002, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Dec 18 04:51:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409666, encodeId=5df91409666a5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Sep 01 12:51:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049539, encodeId=e86d10495395e, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Aug 31 00:51:00 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2080579, encodeId=c94a20805e988, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Jan 17 00:51:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957536, encodeId=6f88195e5366f, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Oct 15 09:51:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771280, encodeId=25d41e7128002, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Dec 18 04:51:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409666, encodeId=5df91409666a5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Sep 01 12:51:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049539, encodeId=e86d10495395e, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Aug 31 00:51:00 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2080579, encodeId=c94a20805e988, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Jan 17 00:51:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957536, encodeId=6f88195e5366f, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Oct 15 09:51:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771280, encodeId=25d41e7128002, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Dec 18 04:51:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409666, encodeId=5df91409666a5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Sep 01 12:51:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049539, encodeId=e86d10495395e, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Aug 31 00:51:00 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2080579, encodeId=c94a20805e988, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Jan 17 00:51:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957536, encodeId=6f88195e5366f, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Oct 15 09:51:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771280, encodeId=25d41e7128002, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Dec 18 04:51:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409666, encodeId=5df91409666a5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Sep 01 12:51:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049539, encodeId=e86d10495395e, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Aug 31 00:51:00 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2018-09-01 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=2080579, encodeId=c94a20805e988, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Thu Jan 17 00:51:00 CST 2019, time=2019-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957536, encodeId=6f88195e5366f, content=<a href='/topic/show?id=b6804e871a8' target=_blank style='color:#2F92EE;'>#工作会议#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47871, encryptionId=b6804e871a8, topicName=工作会议)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/22AEC2EC4805C29C6E1DEE6D888DB41C/100, createdBy=7a322500193, createdName=ms1779634646866130, createdTime=Mon Oct 15 09:51:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771280, encodeId=25d41e7128002, content=<a href='/topic/show?id=f9a840834cd' target=_blank style='color:#2F92EE;'>#国家中医药管理局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40834, encryptionId=f9a840834cd, topicName=国家中医药管理局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d12138235417, createdName=bnurmamat, createdTime=Tue Dec 18 04:51:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409666, encodeId=5df91409666a5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Sep 01 12:51:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049539, encodeId=e86d10495395e, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Fri Aug 31 00:51:00 CST 2018, time=2018-08-31, status=1, ipAttribution=)]
    2018-08-31 运动yd

    中医中药,大多被人诋毁,不过梅斯里总是客观公正的

    0

相关资讯

国家中医药管理局新领导敲定:余艳红任党组书记,于文明任局长

6月28日,国家中医药管理局召开领导干部会议,宣布了中央关于国家中医药管理局主要负责同志任职的决定,余艳红任国家中医药管理局党组书记、副局长,于文明任国家中医药管理局局长。

国家中医药管理局致全国中医护理工作者的慰问信

中医护理是中医药事业的重要组成部分,与中医学同步产生和发展,在长期的临床实践过程中,形成了以整体观念为指导,以中医辨证理论为依据,融传统与现代护理技术为一体的独特的中医护理理论体系和技术操作系统,已经成为中医药综合防治疾病的重要手段之一。中医药系统的护理工作者坚持以人民为中心,牢记南丁格尔誓言,弘扬“敬佑生命、救死扶伤、甘于奉献、大爱无疆”的精神,以忠诚的服务理念、严谨的工作作风和精湛的专业技术,

国家中医药管理局党组召开会议:传达学习贯彻全国宣传思想工作会议精神

国家中医药管理局党组召开会议,传达学习全国宣传思想工作会议精神,研究贯彻落实意见。国家卫生健康委党组成员、国家中医药管理局党组书记余艳红主持会议,局党组成员马建中、王志勇、闫树江出席会议,局长于文明列席会议。

国家中医药管理局加强中医药特色诊疗技术推广

近日,由国家中医药管理局举办的“中医药特色诊疗技术相关情况新闻通气会”在北京召开。会上,国家中医药管理局副局长王志勇表示,“中医药在疾病治疗领域有着独特疗效,我们要把祖先留给我们的中医药宝贵财富发展好、利用好,把真正好的中医药诊疗技术进行推广。”

国家中医药管理局与湖北省政府签署合作协议:推进湖北建设中医药强省

6月5日,国家中医药管理局与湖北省人民政府在湖北武汉签署了《推进湖北建设中医药强省合作框架协议》。根据协议,双方将在中医医院建设发展、中医药服务能力提升、中医药人才队伍建设、中医药产业发展、中医药文化等五个方面进一步深化战略合作。

国家中医药管理局召开干部大会

国家中医药管理局召开干部大会,通报了中央关于王国强不再担任国家中医药管理局党组书记、局长的决定,国家卫生健康委员会党组研究决定由委党组成员、副主任曾益新分管国家中医药管理局,国家中医药管理局党组成员、副局长马建中负责局日常工作。曾益新、王国强出席会议并讲话,马建中主持会议。